Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05150197
Other study ID # Pro00109426
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 19, 2022
Est. completion date February 1, 2025

Study information

Verified date February 2024
Source Duke University
Contact Samuel A Alvarez, MD
Phone 919-684-0560
Email samuel.alvarez544@duke.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality system which has been used in adults and children. This study will compare the performance of the VisuALL to the standard testing for peripheral vision, which is called the Humphrey Visual Field (HVF) test. The study will recruit both healthy children, as well children and young adults who have eye conditions which require visual field testing as part of their standard care. The test will be performed on a day when the child or young adult already has a scheduled eye appointment as standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day of the visit. There are no direct benefits for participants. Selected participants will be also be given training and then loaned a home VisuALL system to allow home visual field testing. If your child is selected, additional information would be provided.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date February 1, 2025
Est. primary completion date February 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 21 Years
Eligibility Inclusion Criteria: - Patients must be 17 years or younger, OR patients from 18-21 years of age must have been diagnosed with their condition prior to their 18th birthday - Cognitively normal (no developmental delay or syndrome) - Be able to tolerate wearing the virtual reality goggles for at least 10 minutes - Be able to provide informed consent of a parent/guardian (and assent if 12 years or older) - Do not have any ocular diseases that could interfere with the visual field testing Exclusion Criteria: - Developmental delay - Inability to obtain consent - Inability to understand English

Study Design


Related Conditions & MeSH terms


Intervention

Device:
VisuALL
Virtual Reality Visual Field Device
Humphrey Visual Field
Standard of care Visual Field test

Locations

Country Name City State
United States Duke University Medical Center Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

References & Publications (2)

Montelongo M, Gonzalez A, Morgenstern F, Donahue SP, Groth SL. A Virtual Reality-Based Automated Perimeter, Device, and Pilot Study. Transl Vis Sci Technol. 2021 Mar 1;10(3):20. doi: 10.1167/tvst.10.3.20. — View Citation

Razeghinejad R, Gonzalez-Garcia A, Myers JS, Katz LJ. Preliminary Report on a Novel Virtual Reality Perimeter Compared With Standard Automated Perimetry. J Glaucoma. 2021 Jan 1;30(1):17-23. doi: 10.1097/IJG.0000000000001670. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mean deviation results of visual field parameters Mean deviation of the visual field is one score measured in decibels calculated from device reading During office visit, approximately 30 minutes
Primary Pattern standard deviation results of visual field parameters Pattern standard deviation of the visual field is one score calculated from device reading During office visit, approximately 30 minutes
Primary Sensitivity results of visual field parameters Sensitivities are the results of each space in the visual field measured in decibels During office visit, approximately 30 minutes
Secondary Percent of times that scotomas were visualized as measured by visual field tests During office visit, approximately 30 minutes
Secondary Percent of participants stating satisfaction as measured by questionnaire 12 questions with strongly disagree to strongly agree During office visit, approximately 5 minutes
Secondary Percent of patients able to use VisuALL home testing as measured by device reading Home testing will be done in a few patients that demonstrate facility with device One month, 1-2 tests per week
Secondary Percent of patients able to use VisuALL in-office testing as measured by patient observation During office visit, approximately 30 minutes
See also
  Status Clinical Trial Phase
Completed NCT05169983 - Feasibility of Visual Field Screening Apps
Recruiting NCT04424979 - Feasibility Tests for Various Prism Configurations for Visual Field Loss N/A
Completed NCT04786886 - Patient Performance and Acceptance of Virtual Reality Visual Field Devices N/A
Recruiting NCT06047717 - Vision Loss Impact on Navigation in Virtual Reality N/A
Recruiting NCT05141604 - Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking N/A
Completed NCT04175444 - Establishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field Analyzer
Recruiting NCT04798924 - Visual Rehabilitation After Occipital Stroke N/A
Recruiting NCT06241209 - Hemianopsia Rehabilitation After Stroke or Brain Injury N/A
Recruiting NCT05085210 - Improving Visual Field Deficits With Noninvasive Brain Stimulation N/A
Completed NCT03797469 - Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin) N/A